CO40 Vision-Related Quality of Life in Patients With Diabetic Macular Edema Treated With Brolucizumab 6 Mg vs Aflibercept 2 Mg in the Kestrel and Kite Studies
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.119
https://www.valueinhealthjournal.com/article/S1098-3015(22)02323-3/fulltext
Title :
CO40 Vision-Related Quality of Life in Patients With Diabetic Macular Edema Treated With Brolucizumab 6 Mg vs Aflibercept 2 Mg in the Kestrel and Kite Studies
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02323-3&doi=10.1016/j.jval.2022.09.119
First page :
Section Title :
Open access? :
No
Section Order :
10774